SUSMED 2021
Tokyo, JP · 3 known investors
SUSMED (サスメド株式会社) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning. The Japanese company serves pharmaceutical companies and medical research institutions, including a marketed prescription app for insomnia.
Founders & leadership
Investors · 3
Frequently asked questions
- What does SUSMED 2021 do?
- SUSMED (サスメド株式会社) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning. The Japanese company serves pharmaceutical companies and medical research institutions, including a marketed prescription app for insomnia.
- Who founded SUSMED 2021?
- SUSMED 2021 was founded by 上野 太郎, Taro Ueno, M.D., Ph.D.
- Who are SUSMED 2021's investors?
- SUSMED 2021's investors include Beyond Next Ventures, DIMENSION, Sony Ventures Corporation.
- Where is SUSMED 2021 headquartered?
- SUSMED 2021 is headquartered in Tokyo, JP.